Key result
Complex PCI with DES was associated with higher 3-year rates of major adverse cardiac and cerebrovascular events compared with noncomplex PCI.
Why the study?
Does high platelet reactivity evaluated by the VerifyNow P2Y12 platelet function test impact 3-year major adverse cardiac and cerebrovascular events in East Asian patients undergoing complex versus noncomplex PCI with DES?
Does high platelet reactivity evaluated by the VerifyNow P2Y12 platelet function test impact 3-year major adverse cardiac and cerebrovascular events in East Asian patients undergoing complex versus noncomplex PCI with DES?
Answers are grounded in this paper and cite their sources.
This editorial highlights that both procedural complexity and high on-treatment platelet reactivity (≥252 PRU) independently increase 3-year ischemic and mortality risks after DES implantation in East Asian patients, supporting the selective use of platelet function testing to guide antiplatelet therapy escalation in complex PCI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) conducted an editorial in Coronary artery disease treated with percutaneous coronary intervention. Complex PCI with drug-eluting stents vs. Noncomplex PCI with drug-eluting stents was evaluated on 3-year major adverse cardiac and cerebrovascular events (MACCE) (adjusted HR 1.21, 95% CI 1.01-1.44, p=0.035). Complex PCI with DES was associated with higher 3-year rates of major adverse cardiac and cerebrovascular events compared with noncomplex PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: